D.E. Shaw & Co
PHVS icon

D.E. Shaw & Co’s Pharvaris PHVS Stock Holding History

D.E. Shaw & Co’s Portfolio PHVS Stock Details PHVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$9.07M Buy
321,157
+60,585
+23% +$1.62M 0.01% 1725
2025
Q4 		$7.23M Buy
260,572
+237,686
+1,039% +$5.72M ﹤0.01% 2028
2025
Q3 		$571K Buy
+22,886
New +$508K ﹤0.01% 3800

Other funds holding PHVS

GA
General Atlantic New York $2.15B AUM 35.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
FCMI
Foresite Capital Management IV Larkspur, California $237M AUM 107.53% 1-Year Est. Return
VP
venBio Partners San Francisco, California $281M AUM 261.03% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
EFM
EQT Fund Management Luxembourg $1.02B AUM
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return

D.E. Shaw & Co's PHVS Position: Q1 2026 in Review

D.E. Shaw & Co increased its Pharvaris (PHVS) stake by 23% in Q1 2026, buying an estimated $1.62M and bringing the position to 321,157 shares worth $9.07M. The position accounts for 0.01% of the portfolio, ranked #1725.

D.E. Shaw & Co first reported a position in PHVS in Q3 2025 and has held it in 3 quarters since. 110 funds tracked by Wall St. Rank hold PHVS as of Q1 2026.

  • D.E. Shaw & Co held 321,157 shares of Pharvaris worth $9.07M as of Q1 2026.
  • D.E. Shaw & Co bought 60,585 Pharvaris shares in Q1 2026, an estimated $1.62M.
  • Pharvaris made up 0.01% of D.E. Shaw & Co's portfolio in Q1 2026, its #1725 holding.
  • D.E. Shaw & Co first reported a position in Pharvaris in Q3 2025 and has held it in 3 quarters since.
  • 110 funds tracked by Wall St. Rank held Pharvaris as of Q1 2026.

Based on D.E. Shaw & Co's 13F filing for Q1 2026, filed 15 May 2026.